Clinical Trials Logo
  1. Home
  2. Parkinsons Disease
  3. NCT01256905

Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies — Armodafinil  

Parkinsons Disease Clinical Trial

Official title:
Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies

Clinical Trial Summary

The purpose of this study is to evaluate if a drug commonly used to treat excessive day-time sleepiness, called armodafinil (Nuvigil), is also effective in improving the impairment in the attention commonly reported by patients with more advanced Parkinson's disease (PD) and Lewy body disease (LBD).

Clinical Trial Description

The main aims of this study are: 1. To investigate whether in PDD and DLB th specific disturbances in the basal ganglia thalamocortical network, measured through the Electroencephalography (EEG) frequency analysis, are ameliorated by armodafinil. Our main hypothesis is that armodafinil can restore the attention and improve cognitive disturbances in PDD and DLB, through a specific effect on striatal-thalamo-cortical activity. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01256905
Study type Interventional
Source NYU Langone Health
Contact
Status Withdrawn
Phase N/A
Start date January 1, 2011
Completion date August 8, 2011
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05565443 - MR-guided Focused Ultrasound Plus GCase N/A
Completed NCT01941732 - Motor Response to Sildenafil in PD Phase 4
Active, not recruiting NCT04777331 - A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease Phase 2
Completed NCT02452125 - The Effects of Nicotine Chewing Gum in Parkinson's Disease N/A
Completed NCT02569021 - Battery-preserving Stimulation Patterns for Deep Brain Stimulation N/A
Recruiting NCT05568199 - Udall Project 1 Aim 4
Completed NCT02676804 - Exercise Dosing Trial for Individuals With Parkinson's Disease N/A
Completed NCT02092181 - A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO) Phase 4
Terminated NCT02249559 - Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease N/A
Completed NCT01163344 - Dance Exercise as Novel Complementary Therapy for Parkinson's Disease N/A
Recruiting NCT05539196 - A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Completed NCT02318927 - A Responsive Closed-Loop Approach to Treat Freezing of Gait in Parkinson's Disease N/A
Active, not recruiting NCT01417598 - BETA Study: Improving Balance Function in Elderly by Progressive and Specific Training and Physical Activity N/A
Completed NCT01789385 - Anesthesia for Deep Brain Stimulation Phase 4
Completed NCT01360229 - Acupuncture for Fatigue in Parkinson's Disease N/A
Recruiting NCT02126475 - Temporal Expectations in Parkinson's Disease N/A